Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2011 Nov;4(6):746-52.
doi: 10.1242/dmm.008185. Epub 2011 Oct 4.

Animal models for Gaucher disease research

Affiliations
Review

Animal models for Gaucher disease research

Tamar Farfel-Becker et al. Dis Model Mech. 2011 Nov.

Abstract

Gaucher disease (GD), the most common lysosomal storage disorder (LSD), is caused by the defective activity of the lysosomal hydrolase glucocerebrosidase, which is encoded by the GBA gene. Generation of animal models that faithfully recapitulate the three clinical subtypes of GD has proved to be more of a challenge than first anticipated. The first mouse to be produced died within hours after birth owing to skin permeability problems, and mice with point mutations in Gba did not display symptoms correlating with human disease and also died soon after birth. Recently, conditional knockout mice that mimic some features of the human disease have become available. Here, we review the contribution of all currently available animal models to examining pathological pathways underlying GD and to testing the efficacy of new treatment modalities, and propose a number of criteria for the generation of more appropriate animal models of GD.

PubMed Disclaimer

Figures

Fig. 1.
Fig. 1.
A timeline of the generation of mouse models of GD. For further details, see text.

References

    1. Cabrera-Salazar M. A., Bercury S. D., Ziegler R. J., Marshall J., Hodges B. L., Chuang W. L., Pacheco J., Li L., Cheng S. H., Scheule R. K. (2010). Intracerebroventricular delivery of glucocerebrosidase reduces substrates and increases lifespan in a mouse model of neuronopathic Gaucher disease. Exp. Neurol. 225, 436–444 - PubMed
    1. Cherin P., Rose C., de Roux-Serratrice C., Tardy D., Dobbelaere D., Grosbois B., Hachulla E., Jaussaud R., Javier R. M., Noel E., et al. (2010). The neurological manifestations of Gaucher disease type 1, the French Observatoire on Gaucher disease (FROG). J. Inherit. Metab. Dis. 33, 331–338 - PubMed
    1. Cullen V., Sardi S. P., Ng J., Xu Y. H., Sun Y., Tomlinson J. J., Kolodziej P., Kahn I., Saftig P., Woulfe J., et al. (2011). Acid beta-glucosidase mutants linked to gaucher disease, parkinson disease, and lewy body dementia alter alpha-synuclein processing. Ann. Neurol. 69, 940–953 - PubMed
    1. Datta S. C., Radin N. S. (1986). Glucosylceramide and the level of the glucosidase-stimulating proteins. Lipids 21, 702–709 - PubMed
    1. Datta S. C., Radin N. S. (1988). Normalization of liver glucosylceramide levels in the “Gaucher” mouse by phosphatidylserine injection. Biochem. Biophys. Res. Commun. 152, 155–160 - PubMed